Hongene to Supply exNA Oligonucleotide Technology Under New Licensing Deal
CDMO Hongene Biotech has entered a non-exclusive licensing agreement with the UMass Chan Medical School to produce and supply extended nucleic acid (exNA) monomers and exNA-modified oligonucleotides for research use.
